Kinara

Articles

View all

October 28, 2025

9 Minute Read

The Conversations We Should Have Had: A Personal and Professional Journey Through Alzheimer’s Disease

Bill Gibson

October 23, 2025

9 Minute Read

Women’s Health, GLP-1s and ‘AI Everywhere’ Drive the Conversation at HLTH 2025

Multiple Authors

October 15, 2025

11 Minute Read

‘Health Above All’: A Q&A With Lilly’s Jennifer Oleksiw

Chase Feiger

October 9, 2025

13 Minute Read

‘Not Playing a Role Isn’t an Option’: Meredith Gannon’s Missions to Transform Marketing and Maternal Care

Larry Dobrow

October 1, 2025

6 Minute Read

‘We Sought the Asset Out’: Inside Iterum’s Race to Reshape the UTI Treatment Market

Larry Dobrow

September 25, 2025

12 Minute Read

Same Question, Different Answer: Fixing AI Wobble in Pharma

Ahmed Elsayyad

Five Questions

View all

September 29, 2025

Randevyn Piérre, Head of U.S. External Affairs, ViiV Healthcare

Randevyn Piérre

September 10, 2025

Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Will McMahon

August 27, 2025

Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Derrick Gastineau

Podcast

View all

September 18, 2025

Health Above All with Eli Lilly’s Jennifer Oleksiw and the CX Revolution

Jennifer Oleksiw

August 5, 2025

The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Devang Bhuva

July 21, 2025

Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Jay Donovan Wu

June 4, 2025

Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Abizer Gaslightwala

April 16, 2025

Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Barry Greene

January 29, 2025

Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Bruce Cozadd

What is Kinara?

Revolutionizing Diagnostics:

Exact Sciences CEO on What’s Next

Advancing Neurohealth:
Alkermes CEO on Innovation
and Progress

Building a First-Tier Pharma Culture:
Bruce Cozadd CEO
of Jazz Pharmaceuticals

Articles

The Conversations We Should Have Had: A Personal and Professional Journey Through Alzheimer’s Disease

Women’s Health, GLP-1s and ‘AI Everywhere’ Drive the Conversation at HLTH 2025

‘Health Above All’: A Q&A With Lilly’s Jennifer Oleksiw

‘Not Playing a Role Isn’t an Option’: Meredith Gannon’s Missions to Transform Marketing and Maternal Care

‘We Sought the Asset Out’: Inside Iterum’s Race to Reshape the UTI Treatment Market

Same Question, Different Answer: Fixing AI Wobble in Pharma

Five Questions

Randevyn Piérre, Head of U.S. External Affairs, ViiV Healthcare

Will McMahon, Director, Omnichannel Strategy, AstraZeneca

Derrick Gastineau, Head of Marketing, Currax Pharmaceuticals

Podcast

Health Above All with Eli Lilly’s Jennifer Oleksiw and the CX Revolution

The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences

Science and Service: Ascendis’ Jay Donovan Wu on Leading with Authenticity in the Rare Disease Space

Breaking Down Barriers: Akari’s CEO on the Future of Cancer Treatment

Transforming Maternal Mental Health: Sage Therapeutics’ CEO on the Future of Postpartum Depression Treatment

Building a First-Tier Pharma Culture: Bruce Cozadd CEO of Jazz Pharmaceuticals

Sign up to join insightful conversations with key life science executives in our monthly newsletter.